Literature DB >> 2422105

Demonstration of vascular endothelium in thyroid carcinomas using Ulex europaeus I agglutinin.

R González-Cámpora, C Montero, I Martin-Lacave, H Galera.   

Abstract

The usefulness of using peroxidase-labelled Ulex europaeus agglutinin I for the staining of small vessels and capillaries in the capsule of thyroid tumours is demonstrated. With this procedure the scanning for small tumour deposits in those vessels and, consequently, the diagnosis of follicular carcinoma of the thyroid is facilitated.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2422105     DOI: 10.1111/j.1365-2559.1986.tb02480.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  6 in total

Review 1.  Handling of thyroid follicular patterned lesions.

Authors:  Juan Rosai
Journal:  Endocr Pathol       Date:  2005       Impact factor: 3.943

2.  Evidence of vascular differentiation in anaplastic tumours of the thyroid--an immunohistological study.

Authors:  F Eckert; U Schmid; F Gloor; C Hedinger
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1986

Review 3.  The utility of some modern techniques in understanding thyroid pathology.

Authors:  Virginia A LiVoisi
Journal:  Endocr Pathol       Date:  1990-06       Impact factor: 3.943

4.  Prognostic value of the immunocytochemical detection of extramural venous invasion in Dukes' C colorectal adenocarcinomas. A preliminary study.

Authors:  G Lapertosa; P Baracchini; E Fulcheri; R Tanzi
Journal:  Am J Pathol       Date:  1989-11       Impact factor: 4.307

5.  An Evaluation of CD61 Immunohistochemistry in Identification of Vascular Invasion in Follicular Thyroid Neoplasms.

Authors:  Vincent Cracolici; Megan Parilla; Kammi J Henriksen; Nicole A Cipriani
Journal:  Head Neck Pathol       Date:  2019-06-19

6.  Follicular thyroid carcinoma invades venous rather than lymphatic vessels.

Authors:  Xiaoqi Lin; Bing Zhu; Yulin Liu; Jan F Silverman
Journal:  Diagn Pathol       Date:  2010-01-22       Impact factor: 2.644

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.